COLD CAPSULE IV
LOE Approachingchlorpheniramine maleate; phenylpropanolamine hydrochloride
NDAORALCAPSULE, EXTENDED RELEASE
Approved
Apr 1985
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
COLD CAPSULE IV (chlorpheniramine maleate; phenylpropanolamine hydrochloride). Approved for these symptoms due to hay fever, other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose and 1 more indications. First approved in 1985.
Drug data last refreshed 6h ago · AI intelligence enriched 2d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
COLD CAPSULE IV is an oral extended-release capsule combining chlorpheniramine maleate (antihistamine) and phenylpropanolamine hydrochloride (decongestant) approved in 1985. It treats upper respiratory allergy symptoms including runny nose, itchy/watery eyes, sneezing, and throat itching associated with hay fever and other allergies. The combination provides symptomatic relief through dual antihistamine and decongestant mechanisms.
LOE Approaching
As an aging product approaching loss of exclusivity with moderate competitive pressure (30), career growth on this brand will focus on defensive positioning and transition planning rather than expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.